BMS-986360/CC-90001

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-986360/CC-90001, covering 2025-06-13 to 2025-06-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BMS-986360/CC-90001 Alone and in Combination With Chemotherapy or Nivolumab in Advanced Solid Tumors [Phase 1]

See pricing